Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Skin neoplasms malignant and unspecified (excl melanoma)
ADR ID BADD_A04054
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.03      Skin neoplasms malignant and unspecified
16.03.02      Skin neoplasms malignant and unspecified (excl melanoma)
23      Skin and subcutaneous tissue disorders
23.08      Skin neoplasms malignant and unspecified
23.08.02      Skin neoplasms malignant and unspecified (excl melanoma)
Description Not Available
MedDRA Code 10040901
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D02002Selegiline
BADD_D02016Sibutramine
BADD_D02018Sildenafil
BADD_D02026Simvastatin
BADD_D02028Sirolimus
BADD_D02031Sitaxentan
BADD_D02053Sofosbuvir
BADD_D02058Sorafenib
BADD_D02093Sulfasalazine
BADD_D02100Sunitinib
BADD_D02104Tacrine hydrochloride
BADD_D02105Tacrolimus
BADD_D02106Tadalafil
BADD_D02150Temozolomide
BADD_D02165Teriflunomide
BADD_D02170Testosterone
BADD_D02192Thalidomide
BADD_D02210Tiagabine
BADD_D02211Tiagabine hydrochloride
BADD_D02230Tizanidine
BADD_D02231Tizanidine hydrochloride
BADD_D02236Tofacitinib
BADD_D02237Tofacitinib citrate
BADD_D02241Tolcapone
BADD_D02252Tositumomab
BADD_D02322Ustekinumab
BADD_D02325Valdecoxib
BADD_D02331Valsartan
BADD_D02344Vemurafenib
BADD_D02345Venetoclax
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages